What is MDC Associates?
MDC Associates operates as a dedicated CRO, providing comprehensive support to in vitro diagnostic (IVD) companies navigating complex clinical, regulatory, and quality system challenges. Their service portfolio encompasses clinical study management, regulatory strategy development, and quality system planning. Catering to a diverse clientele ranging from emerging startups to established firms within the IVD sector, MDC Associates places a strong emphasis on infectious diseases and clinical chemistry. The organization is distinguished by its collaborative ethos and unwavering commitment to client success, delivering bespoke strategies designed to mitigate risks and adhere to project timelines.
How much funding has MDC Associates raised?
MDC Associates has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in MDC Associates
PPP
Public-Private Partnership
What's next for MDC Associates?
The substantial late-stage funding positions MDC Associates for accelerated expansion and enhanced service delivery. This strategic investment is anticipated to fuel advancements in their operational capabilities, potentially broadening their service offerings and deepening their expertise in critical areas like infectious disease diagnostics. The company is poised to further solidify its market leadership by leveraging this capital to scale its operations, invest in talent, and potentially explore new technological integrations to better serve the evolving needs of the IVD industry. This financing round signals strong investor confidence in MDC Associates' business model and its capacity to drive innovation and regulatory compliance within the diagnostic sector.
See full MDC Associates company page
